Emergent Biosolutions EBS Work in process
Work in process at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's work in process.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's work in process?
- Emergent Biosolutions (EBS) reported work in process of $82.9M in Q1 2026.
- How has Emergent Biosolutions's work in process changed year-over-year?
- Emergent Biosolutions's work in process decreased by 18.1% year-over-year, from $101.2M to $82.9M.
- What is the long-term trend for Emergent Biosolutions's work in process?
- Over 5 years (2020 to 2025), Emergent Biosolutions's work in process has grown at a 1.2% compound annual growth rate (CAGR), from $102.5M to $109M.
- What does work in process mean?
- Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.